Identification of a Transaminative Pathway for Ethionine Catabolism1
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Prebiotic Synthesis of Methionine and Other Sulfur-Containing Organic Compounds on the Primitive Earth: a Contemporary Reassessm
PREBIOTIC SYNTHESIS OF METHIONINE AND OTHER SULFUR-CONTAINING ORGANIC COMPOUNDS ON THE PRIMITIVE EARTH: A CONTEMPORARY REASSESSMENT BASED ON AN UNPUBLISHED 1958 STANLEY MILLER EXPERIMENT Eric T. ParkerL*, H. James Cleaves2, Michael P. Callahan, Jason P. Dworkin 3, Daniel P. Glavin, Antonia Lazcanoa, and Jeffrey L. Badal Scripps Institution of Oceanography, University of California at San Diego, La Jolla, CA 92093, ; A5. 'Geophysical Laboratory, Carnegie Institution of Washington, 5251. Broad Branch Rd. NW, "Washington, DC 20015, USA; 3'LTASA Goddard Space flight Center, Solar System Exploration Division, Greenbelt, MD 20771, USA; 4Facultad de Ciencias, UNAM, Apdo. Postal 74-447 Cd. Universitaria, 04510 Mexico D. F., Mexico Address correspondence to: Jeffrey L. Bada, Scripps Institution of Oceanography, University of California at San Diego, 8615 Kennel Way, La Jolla, CA 92093-0212, USA; phone: 858 534- 4258; fax: 858 534-2995; email; jb d < cscl.c i * Present address, School of Earth & Atmospheric Sciences, Georgia Institute of Technology,. Atlanta, GA 34332, USA ABSTRACT Original extracts from an unpublished 1958 experiment conducted by the late Stanley L. Miller were recently found and analyzed using modern state-of-the-art analytical methods. The extracts were produced by the action of an electric discharge on a mixture of methane (CU4), hydrogen sulfide (H2S), ammonia (NH3), and carbon dioxide (CO2). Racemic methionine was farmed in significant yields, together with other sulfur-bearing organic compounds. The formation of methionine and other compounds from a model prebiotic atmosphere that contained H2S suggests that this type of synthesis is robust under reducing conditions, which may have existed either in the global primitive atmosphere or in localized volcanic environments on the early Earth. -
Methionine Production – a Critical Review
The final publication is available at link Springer.com Methionine Production – a Critical Review THOMAS WILLKE Thünen-Institute of Agricultural Technology Bundesallee 50, 38116 Braunschweig, German E-mail [email protected], tel +49 531 596 4124, fax +49 531 596 4199 Abstract This paper presents an updated critical review about several attempts to contribute methionine (Met) to the world market with an emphasis on fermentation processes, especially from natural biological sources. Analytical methods for the determination of methionine are reviewed as well as applications in feed, food, pharmacy and medicine. Fermentation studies published within the last five decades are elucidated critically; mainly with respect to the sulfur balance, substrate yield, and the analytical validity. From all the published fermentation data it can be concluded that up to now no more than 5 g/L methionine are achievable without using genetically modified organisms (GMOs). The very highest L-methionine concentration from natural sources reached so far amounts to 35 g/L and is published as a patent using a GMO of Escherichia coli (E. coli). The review closes with a comprehensive overview of the role and activities of global methionine manufacturers. Some current market data is also presented. Keywords Methionine, Fermentation, Analytical methods, Sulfur balance, World market, Manufacturers Introduction Sulfur-containing amino acids had already been detected in 1847 at Liebig’s laboratory by Fleitmann (1848). He discovered the heat instability of proteins in strong alkali solutions, liberating H2S and NH3. Later, Osborne (1902) determined in highly purified proteins two sulfur containing amino acids and correctly attributed one of them to cysteine. -
WARNER/2014-12-02/Defs' Expert Report/6368
December 2, 2014 Mr. John D. Hadden Assistant Attorney General Litigation Division Office of the Attorney General 313 North East 21st Street Oklahoma City, OK 73105 Re: Charles F. Warner, et al, v. Gross, et al, No CIV-14-665F Dear Mr. Hadden: I have been requested to address the pharmacological effects of the drugs used in the execution protocol for the State of Oklahoma. The following outlines the classification of the drugs in the protocol, their mechanisms of action, dosing in therapeutic use and the consequences of toxic doses as outlined in AttachmentAttachment D1, Charts A-D. 1) Midazolam Midazolam is a short acting benzodiazepine which is use as a pre-anesthetic agent for routine medical procedures to allay patient apprehension, create amnesia, and anesthesia induction. It produces different levels of central nervous system (CNS) depression through binding to gamma-aminobutyric acid (GABA) receptors. It is available in an injectable dosage form. Once the drug is administered the onset of action is 1.5-5 minutes. It is widely distributed after administration and crosses the blood brain barrier. Maximum effects are seen in 20-60 minutes with recovery occurring in 2-6 hours. Serious adverse events include cardiac arrest, agitation, apnea and respiratory depression/arrest. The drug can result in depression of the spinal reflexes and reticular activating system leading to coma and respiratory arrest. The drug will potentiate the effect of other central nervous system depressants, such as ethanol, opioids and sedative hypnotics. When given together with opioids, the dose of both drugs can be reduced. The therapeutic dose as a pre-anesthetic for adults is 1.5 – 3.5 mg for a 70kg adult less than sixty years old with a maximum recommended dose of 5mg intravenously. -
Naming and Indexing of Chemical Substances for Chemical Abstractstm
Naming and Indexing of Chemical Substances for Chemical AbstractsTM 2007 Edition A publication of Chemical Abstracts Service Published by the American Chemical Society Naming and Indexing of Chemical Substances for Chemical AbstractsTM A publication of Chemical Abstracts Service Published by the American Chemical Society Copyright © 2008 American Chemical Society All Rights Reserved. Printed in the USA Inquiries concerning editorial content should be sent to: Editorial Office, Chemical Abstracts Service, 2540 Olentangy River Road, P.O. Box 3012, Columbus, Ohio 43210-0012 USA SUBSCRIPTION INFORMATION Questions about CAS products and services should be directed to: United States and Canada: CAS Customer Care Phone: 800-753-4227 (North America) 2540 Olentangy River Road 614-447-3700 (worldwide) P.O. Box 3012 Fax: 614-447-3751 Columbus, Ohio 43210-0012 USA E-mail: [email protected] Japan: JAICI (Japan Association for International Phone: 81-3-5978-3621 Chemical Information) Fax: 81-3-5978-3600 6-25-4 Honkomagome E-mail: [email protected] Bunkyo-ku, Tokyo Japan, 113-0021 Countries not named above: Contact CAS Customer Care, 2540 Olentangy River Road, P.O. Box 3012, Columbus, Ohio 43210-0012 USA; Telephone 614-447-3700; Fax 614-447-3751; E-mail [email protected]. For a list of toll-free numbers from outside North America, visit www.cas.org. 1 Naming and Indexing of Chemical Substances for Chemical Abstracts 2007 ¶ 102 NAMING AND INDEXING OF CHEMICAL SUBSTANCES 101. Foreword. Although the account which follows describes in consid- zwitterions (inner salts, sydnones). The changes for the Fourteenth (1997- erable detail the selection of substance names for Chemical Abstracts (CA) in- 2001) Collective Index period affect coordination nomenclature, stereochemi- dexes, it is not a nomenclature manual.